-
1
Optimizing ibrutinib bioavailability: Formulation and assessment of hydroxypropyl-β-cyclodextrin-based nanosponge delivery systems
Published 2025-01-01“…Current Research in Pharmacology and Drug Discovery…”
Get full text
Article -
2
The suppression of the SPHK1/S1P/S1PR3 signaling pathway diminishes EGFR activation and increases the sensitivity of non-small cell lung cancer to gefitinib
Published 2025-01-01“…Current Research in Pharmacology and Drug Discovery…”
Get full text
Article